[OEstradiol and progesterone steroid hormone receptors in cancer of the endometrium. The significance of the progesterone receptor (author's transl)].
It would seem that the satisfactory way for the clinician to orientate the treatment by hormones in cancers of the endometrium lies in the presence at the same time of oestrogen and progesterone receptors and in particular of the latter. This applies when treating cancers of the endometrium with hormones in a way that is directed by chemical determination of hormone susceptibility.
D004717:Endometrium; D004958:Estradiol / Q000378:metabolism*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use; D009653:Norprogesterones / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000187:drug effects* / Q000378:metabolism; D011980:Receptors, Progesterone / Q000187:drug effects* / Q000378:metabolism; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
D009653:Norprogesterones; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D004958:Estradiol; C011214:demegestone; D008525:Medroxyprogesterone
Les récepteurs hormonaux stéroïdiens de l'estradiol et de la progestérone dans les cancers de l'endomètre. Signification du récepteur de la progestérone.